MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00381-024-06729-6

Медицинская библиотека · Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025

Comparative analysis of treatment modalities for pediatric spinal cord glioblastoma: insights from a meta-analysis.

Da Cunha Artur Henrique Galvao Bruno, Guerra Pedro Lucas Negromonte, da Silva Inaê Carolline Silveira, Júnior Deoclides Lima Bezerra, de Carvalho Júnior Eduardo Vieira

СтатьяМетаанализСравнительное исследованиеОбзорПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

Glioblastomas (GBM) are aggressive tumors that make up about 7% of central nervous system tumors in children. Spinal GBMs (sGBMs) are extremely rare, accounting for less than 1% of pediatric spinal tumors. sGBMs are difficult to treat due to their infiltrative nature and cause significant morbidity. While there is extensive literature on treatment outcomes for cranial GBMs, there is limited research on pediatric sGBMs. This meta-analysis aims to assess the impact of available treatments on overall survival (OS) and progression-free survival (PFS) in pediatric sGBM patients and to identify prognostic factors.

METHODOLOGY: A comprehensive review of pediatric sGBM cases up to June 2024 was conducted using PubMed and Mendeley. Inclusion criteria were case series and case reports of pediatric sGBM, excluding those with metastatic sGBM or aggregated patient data. A total of 2202 articles were identified, with 46 meeting the inclusion criteria. Data on demographics, tumor characteristics, extent of resection, and treatments were collected. Kaplan-Meier and Cox proportional hazards models were used for statistical analysis.

RESULTS

The data was collected from 81 patients, 43 females and 38 males, with an average age of 10.7 years. The majority of tumors were found in the cervical region (32%). Subtotal resection (STR) was performed in 53% of cases, and 59% of patients received both chemotherapy (QT) and radiotherapy (RT). The average progression-free survival (PFS) was 10.95 months, with RT significantly improving PFS (15.2 months vs. 2.1 months, p = 0.001). The average OS was 13.4 months, with RT and QT being significant protective factors (p < 0.05). Age over seven years and cervical tumor location were associated with worse OS.

CONCLUSION

This study highlights the significance of radiation therapy and chemotherapy in enhancing overall survival and progression-free survival in pediatric patients with spinal cord glioblastoma. Specifically, RT significantly improves PFS, while advanced age and tumor location in the cervical region are associated with worse outcomes. These findings can help shape treatment approaches and ultimately enhance the quality of life for pediatric sGBM patients.

Для цитирования: Da Cunha Artur Henrique Galvao Bruno, Guerra Pedro Lucas Negromonte, da Silva Inaê Carolline Silveira, Júnior Deoclides Lima Bezerra, de Carvalho Júnior Eduardo Vieira. Comparative analysis of treatment modalities for pediatric spinal cord glioblastoma: insights from a meta-analysis.. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery. 2025. DOI: 10.1007/s00381-024-06729-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.